Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 13 June 1997: Vol. 276. no. 5319, pp. 1696 - 1699 DOI: 10.1126/science.276.5319.1696
|
|
Reports
Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural Cytokine
Steven E. Cwirla,
Palaniappan Balasubramanian,
David J. Duffin,
Christopher R. Wagstrom,
Christian M. Gates,
Sara C. Singer,
Ann M. Davis,
Robert L. Tansik,
Larry C. Mattheakis,
Chris M. Boytos,
Peter J. Schatz,
David P. Baccanari,
Nicholas C. Wrighton,
Ronald W. Barrett,
William J. Dower
*
Two families of small peptides that bind to the human
thrombopoietin receptor and compete with the binding of the natural ligand thrombopoietin (TPO) were identified from recombinant
peptide libraries. The sequences of these peptides were not found in
the primary sequence of TPO. Screening libraries of variants of one of
these families under affinity-selective conditions yielded a 14-amino
acid peptide (Ile-Glu-Gly-Pro-Thr-Leu-Arg-Gln-Trp-Leu-Ala-Ala-Arg-Ala) with high affinity (dissociation constant 2 nanomolar) that stimulates the proliferation of a TPO-responsive Ba/F3 cell line with a
median effective concentration (EC50) of 400 nanomolar. Dimerization of this peptide by a carboxyl-terminal linkage to a lysine
branch produced a compound with an EC50 of 100 picomolar, which was equipotent to the 332-amino acid natural cytokine in cell-based assays. The peptide dimer also stimulated the in vitro proliferation and maturation of megakaryocytes from human bone marrow
cells and promoted an increase in platelet count when administered to
normal mice.
S. E. Cwirla, P. Balasubramanian, D. J. Duffin, C. R. Wagstrom, C. M. Gates, A. M. Davis, L. C. Mattheakis, P. J. Schatz, N. C. Wrighton,
R. W. Barrett, W. J. Dower, Affymax Research Institute, 4001 Miranda
Avenue, Palo Alto, CA 94304, USA.
S. C. Singer, R. L. Tansik, C. M. Boytos, D. P. Baccanari, Glaxo
Wellcome Research Institute, Research Triangle Park, NC 27709, USA.
*
To whom correspondence should be addressed.
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia.
- I. C. Macdougall, J. Rossert, N. Casadevall, R. B. Stead, A.-M. Duliege, M. Froissart, and K.-U. Eckardt (2009)
N. Engl. J. Med.
361, 1848-1855
| Abstract »
| Full Text »
| PDF »
- Identification of a Met-Binding Peptide from a Phage Display Library.
- P. Zhao, T. Grabinski, C. Gao, R. S. Skinner, T. Giambernardi, Y. Su, E. Hudson, J. Resau, M. Gross, G. F. Vande Woude, et al. (2007)
Clin. Cancer Res.
13, 6049-6055
| Abstract »
| Full Text »
| PDF »
- New thrombopoietic growth factors.
- D. J. Kuter (2007)
Blood
109, 4607-4616
| Abstract »
| Full Text »
| PDF »
- Low SCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells.
- P. B. de la Grange, F. Armstrong, V. Duval, M.-C. Rouyez, N. Goardon, P.-H. Romeo, and F. Pflumio (2006)
Blood
108, 2998-3004
| Abstract »
| Full Text »
| PDF »
- A rationally designed agonist antibody fragment that functionally mimics thrombopoietin.
- S. Frederickson, M. W. Renshaw, B. Lin, L. M. Smith, P. Calveley, J. P. Springhorn, K. Johnson, Y. Wang, X. Su, Y. Shen, et al. (2006)
PNAS
103, 14307-14312
| Abstract »
| Full Text »
| PDF »
- A dimeric Peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity..
- S. Aggarwal, P. Singh, O. Topaloglu, J. T. Isaacs, and S. R. Denmeade (2006)
Cancer Res.
66, 9171-9177
| Abstract »
| Full Text »
| PDF »
- Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation.
- V. Hamelin, C. Letourneux, P.-H. Romeo, F. Porteu, and M. Gaudry (2006)
Blood
107, 3106-3113
| Abstract »
| Full Text »
| PDF »
- EphB Receptor-binding Peptides Identified by Phage Display Enable Design of an Antagonist with Ephrin-like Affinity.
- M. Koolpe, R. Burgess, M. Dail, and E. B. Pasquale (2005)
J. Biol. Chem.
280, 17301-17311
| Abstract »
| Full Text »
| PDF »
- IFN Regulatory Factor-2 Cooperates with STAT1 to Regulate Transporter Associated with Antigen Processing-1 Promoter Activity.
- M.-C. Rouyez, M. Lestingi, M. Charon, S. Fichelson, A. Buzyn, and I. Dusanter-Fourt (2005)
J. Immunol.
174, 3948-3958
| Abstract »
| Full Text »
| PDF »
- Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities.
- K. Inagaki, T. Oda, Y. Naka, H. Shinkai, N. Komatsu, and H. Iwamura (2004)
Blood
104, 58-64
| Abstract »
| Full Text »
| PDF »
- Selective Modification of Eukaryotic Initiation Factor 4F (eIF4F) at the Onset of Cell Differentiation: Recruitment of eIF4GII and Long-Lasting Phosphorylation of eIF4E.
- S. Caron, M. Charon, E. Cramer, N. Sonenberg, and I. Dusanter-Fourt (2004)
Mol. Cell. Biol.
24, 4920-4928
| Abstract »
| Full Text »
| PDF »
- Mechanistic Diversity of Cytokine Receptor Signaling Across Cell Membranes.
- R. M. Stroud and J. A. Wells (2004)
Sci. STKE
2004, re7
| Abstract »
| Full Text »
| PDF »
- Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen.
- S. E. Lupold and R. Rodriguez (2004)
Mol. Cancer Ther.
3, 597-603
| Abstract »
| Full Text »
| PDF »
- Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis.
- E. Ravet, D. Reynaud, M. Titeux, B. Izac, S. Fichelson, P.-H. Romeo, A. Dubart-Kupperschmitt, and F. Pflumio (2004)
Blood
103, 3326-3335
| Abstract »
| Full Text »
| PDF »
- STAT5 and Oct-1 Form a Stable Complex That Modulates Cyclin D1 Expression.
- S. Magne, S. Caron, M. Charon, M.-C. Rouyez, and I. Dusanter-Fourt (2003)
Mol. Cell. Biol.
23, 8934-8945
| Abstract »
| Full Text »
| PDF »
- Selection of Chronic Lymphocytic Leukemia Binding Peptides.
- S. Takahashi, H. Mok, M. B. Parrott, F. C. Marini III, M. Andreeff, M. K. Brenner, and M. A. Barry (2003)
Cancer Res.
63, 5213-5217
| Abstract »
| Full Text »
| PDF »
- Design of Potent Peptide Mimetics of Brain-derived Neurotrophic Factor.
- P. D. O'Leary and R. A. Hughes (2003)
J. Biol. Chem.
278, 25738-25744
| Abstract »
| Full Text »
| PDF »
- Selective Binding and Oligomerization of the Murine Granulocyte Colony-stimulating Factor Receptor by a Low Molecular Weight, Nonpeptidyl Ligand.
- M. L. Doyle, S.-S. Tian, S. G. Miller, L. Kessler, A. E. Baker, M. R. Brigham-Burke, S. B. Dillon, K. J. Duffy, R. M. Keenan, R. Lehr, et al. (2003)
J. Biol. Chem.
278, 9426-9434
| Abstract »
| Full Text »
| PDF »
- Phage-displayed Peptides Bind to the Malarial Protein Apical Membrane Antigen-1 and Inhibit the Merozoite Invasion of Host Erythrocytes.
- F. Li, A. Dluzewski, A. M. Coley, A. Thomas, L. Tilley, R. F. Anders, and M. Foley (2002)
J. Biol. Chem.
277, 50303-50310
| Abstract »
| Full Text »
| PDF »
- Yohimbine Dimers Exhibiting Selectivity for the Human alpha 2c-Adrenoceptor Subtype.
- S. G. Lalchandani, L. Lei, W. Zheng, M. M. Suni, B. M. Moore, S. B. Liggett, D. D. Miller, and D. R. Feller (2002)
J. Pharmacol. Exp. Ther.
303, 979-984
| Abstract »
| Full Text »
| PDF »
- Recombinant human thrombopoietin: basic biology and evaluation of clinical studies.
- D. J. Kuter and C. G. Begley (2002)
Blood
100, 3457-3469
| Abstract »
| Full Text »
| PDF »
- Thrombopoietin as a Drug: Biologic Expectations, Clinical Realities, and Future Directions.
- I. C. Haznedaroglu, H. Goker, M. Turgut, Y. Buyukasik, and M. Benekli (2002)
Clinical and Applied Thrombosis/Hemostasis
8, 193-212
| Abstract »
| PDF »
- Induction of Neuronal Differentiation by a Peptide Corresponding to the Homophilic Binding Site of the Second Ig Module of the Neural Cell Adhesion Molecule.
- V. Soroka, D. Kiryushko, V. Novitskaya, L. C. B. Ronn, F. M. Poulsen, A. Holm, E. Bock, and V. Berezin (2002)
J. Biol. Chem.
277, 24676-24683
| Abstract »
| Full Text »
| PDF »
- Peptides Identify the Critical Hotspots Involved in the Biological Activation of the Insulin Receptor.
- R. C. Pillutla, K.-c. Hsiao, J. R. Beasley, J. Brandt, S. Ostergaard, P. H. Hansen, J. C. Spetzler, G. M. Danielsen, A. S. Andersen, R. E. Brissette, et al. (2002)
J. Biol. Chem.
277, 22590-22594
| Abstract »
| Full Text »
| PDF »
- Identification of Novel Non-phosphorylated Ligands, Which Bind Selectively to the SH2 Domain of Grb7.
- S. C. Pero, L. Oligino, R. J. Daly, A. L. Soden, C. Liu, P. P. Roller, P. Li, and D. N. Krag (2002)
J. Biol. Chem.
277, 11918-11926
| Abstract »
| Full Text »
| PDF »
- Cloning and Characterization of a Family of Proteins Associated with Mpl.
- C. Meunier, D. Bordereaux, F. Porteu, S. Gisselbrecht, S. Chretien, and G. Courtois (2002)
J. Biol. Chem.
277, 9139-9147
| Abstract »
| Full Text »
| PDF »
- Selective Targeting and Inducible Destruction of Human Cancer Cells by Retroviruses with Envelope Proteins Bearing Short Peptide Ligands.
- T. J. Gollan and M. R. Green (2002)
J. Virol.
76, 3564-3569
| Abstract »
| Full Text »
| PDF »
- Thrombopoietin therapy increases platelet yields in healthy platelet donors.
- D. J. Kuter, L. T. Goodnough, J. Romo, J. DiPersio, R. Peterson, D. Tomita, W. Sheridan, and J. McCullough (2001)
Blood
98, 1339-1345
| Abstract »
| Full Text »
| PDF »
- Thrombopoietin-Mediated Sustained Activation of Extracellular Signal-Regulated Kinase in UT7-Mpl Cells Requires Both Ras-Raf-1- and Rap1-B-Raf-Dependent Pathways.
- J. Garcia, J. de Gunzburg, A. Eychène, S. Gisselbrecht, and F. Porteu (2001)
Mol. Cell. Biol.
21, 2659-2670
| Abstract »
| Full Text »
- IL-2R{beta} Agonist P1-30 Acts in Synergy with IL-2, IL-4, IL-9, and IL-15: Biological and Molecular Effects.
- R. Eckenberg, J.-L. Moreau, O. Melnyk, and J. Theze (2000)
J. Immunol.
165, 4312-4318
| Abstract »
| Full Text »
| PDF »
- Search and Discovery Strategies for Biotechnology: the Paradigm Shift.
- A. T. Bull, A. C. Ward, and M. Goodfellow (2000)
Microbiol. Mol. Biol. Rev.
64, 573-606
| Abstract »
| Full Text »
| PDF »
- Erythropoietin mimetic peptides and the future.
- D. L. Johnson and L. K. Jolliffe (2000)
Nephrol. Dial. Transplant.
15, 1274-1277
| Full Text »
| PDF »
- Selection of Estrogen Receptor {beta}- and Thyroid Hormone Receptor {beta}-Specific Coactivator-Mimetic Peptides Using Recombinant Peptide Libraries.
- J. P. Northrop, D. Nguyen, S. Piplani, S. E. Olivan, S. T-S. Kwan, N. F. Go, C. P. Hart, and P. J. Schatz (2000)
Mol. Endocrinol.
14, 605-622
| Abstract »
| Full Text »
- Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers.
- L. A. Harker, L. K. Roskos, U. M. Marzec, R. A. Carter, J. K. Cherry, B. Sundell, E. N. Cheung, D. Terry, and W. Sheridan (2000)
Blood
95, 2514-2522
| Abstract »
| Full Text »
| PDF »
- The First {alpha} Helix of Interleukin (Il)-2 Folds as a Homotetramer, Acts as an Agonist of the IL-2 Receptor {beta} Chain, and Induces Lymphokine-Activated Killer Cells.
- R. Eckenberg, T. Rose, J.-L. Moreau, R. Weil, F. Gesbert, S. Dubois, D. Tello, M. Bossus, H. Gras, A. Tartar, et al. (2000)
J. Exp. Med.
191, 529-540
| Abstract »
| Full Text »
| PDF »
- An Agonist Murine Monoclonal Antibody to the Human c-Mpl Receptor Stimulates Megakaryocytopoiesis.
- B. Deng, N. Banu, B. Malloy, P. Hass, J. F. Wang, L. Cavacini, D. Eaton, and H. Avraham (1998)
Blood
92, 1981-1988
| Abstract »
| Full Text »
| PDF »
- Thrombopoietin.
- K. Kaushansky (1998)
N. Engl. J. Med.
339, 746-754
| Full Text »
| PDF »
- A Small, Nonpeptidyl Mimic of Granulocyte-Colony- Stimulating Factor.
- S. Tian, P. Lamb, A. G. King, S. G. Miller, L. Kessler, J. I. Luengo, L. Averill, R. K. Johnson, J. G. Gleason, L. M. Pelus, et al. (1998)
Science
281, 257-259
| Abstract »
| Full Text »
- Directed evolution of an aspartate aminotransferase with new substrate specificities.
- T. Yano, S. Oue, and H. Kagamiyama (1998)
PNAS
95, 5511-5515
| Abstract »
| Full Text »
| PDF »
- The Role of the Hinge Region of the Luteinizing Hormone Receptor in Hormone Interaction and Signal Generation.
- H. Zeng, T. Phang, Y. S. Song, I. Ji, and T. H. Ji (2001)
J. Biol. Chem.
276, 3451-3458
| Abstract »
| Full Text »
| PDF »
|
|